Accessibility Menu

VivoSim Labs

(NASDAQ) VIVS

Current Price$1.04
Market Cap$2.79M
Since IPO (2012)-100%
5 Year-99%
1 Year-31%
1 Month-17%

VivoSim Labs Financials at a Glance

Market Cap

$2.79M

Revenue (TTM)

$142.00K

Net Income (TTM)

-$1.23M

EPS (TTM)

$0.47

P/E Ratio

2.30

Dividend

$0.00

Beta (Volatility)

0.74 (Low)

Price

$1.04

Volume

47,062.247

Open

$1.09

Previous Close

$1.07

Daily Range

$1.03 - $1.13

52-Week Range

$1.03 - $5.30

Estimated Earnings Date

May 29, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About VivoSim Labs

Industry

Biotechnology

Employees

13

CEO

Keith Murphy

Website

vivosim.ai

Headquarters

San Diego, CA 92121, US

VIVS Financials

Key Financial Metrics (TTM)

Gross Margin

100.00%

Operating Margin

-8066.20%

Net Income Margin

-864.08%

Return on Equity

-15.56%

Return on Capital

-110.34%

Return on Assets

-17.63%

Earnings Yield

43.48%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.79M

Shares Outstanding

2.61M

Volume

47.06K

Avg. Volume

60.59K

Financials (TTM)

Gross Profit

$142.00K

Operating Income

-$11.45M

EBITDA

-$979.00K

Operating Cash Flow

-$10.62M

Capital Expenditure

$0.00

Free Cash Flow

-$10.62M

Cash & ST Invst.

$4.29M

Total Debt

$577.00K

VivoSim Labs Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$26.00K

+8.3%

Gross Profit

$26.00K

+18.2%

Gross Margin

100.00%

N/A

Market Cap

$2.79M

N/A

Market Cap/Employee

$199.32K

N/A

Employees

14

N/A

Net Income

-$2.69M

+21.9%

EBITDA

-$2.64M

+21.9%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$4.29M

+269.3%

Total Debt

$577.00K

-45.6%

Accounts Receivable

$1.04M

+3915.4%

Inventory

$0.00

N/A

Long Term Debt

$44.00K

-91.9%

Short Term Debt

$533.00K

+3.1%

Return on Assets

-17.63%

N/A

Return on Invested Capital

-2.55%

N/A

Free Cash Flow

-$2.27M

-26.1%

Operating Cash Flow

-$2.27M

-26.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KTTAPasithea Therapeutics Corp.
$0.54-0.83%
PMCBPharmaCyte Biotech, Inc.
$0.72-4.63%
RADXRadiopharm Theranostics Limited
$4.08-5.89%
XTLBXTL Biopharmaceuticals Ltd.
$2.22-13.45%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.57+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.63+0.02%
BBBlackBerry
$11.03+0.07%
SDOTSadot Group
$19.06+2.08%

Questions About VIVS

What is the current price of VivoSim Labs?

VivoSim Labs is trading at $1.04 per share.

What is the 52-week range for VivoSim Labs?

Over the past 52 weeks, VivoSim Labs has traded between $1.03 and $5.30.

How much debt does VivoSim Labs have?

As of the most recent reporting period, VivoSim Labs reported total debt of $812.00K.

How much cash does VivoSim Labs have on hand?

VivoSim Labs reported $4.29M in cash and cash equivalents in its most recent financial results.

What is VivoSim Labs’s dividend yield?

VivoSim Labs does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.